Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

REBEKAH ADIA NEAL

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1215165667
CMS profile
99789
Location
LOS ALAMITOS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$7,630.79

142 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 142 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

REBEKAH ADIA NEAL

NPI 1215165667 · CMS profile ID 99789

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

LOS ALAMITOS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 142 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1215165667?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
REBEKAH ADIA NEAL, NPI 1215165667, CMS profile ID 99789. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 142 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1215165667?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). REBEKAH ADIA NEAL, NPI 1215165667, CMS profile ID 99789. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 142 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1215165667?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
REBEKAH ADIA NEAL, NPI 1215165667, CMS profile ID 99789, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 142 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1215165667?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

142 matching records · $7,630.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 142 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 142.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $39.8309/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370799 CMS
Novartis Pharmaceuticals Corporation $21.1209/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042031 CMS
AbbVie Inc. $24.2609/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722050611 CMS
Radius Health, Inc. $17.5508/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746278909 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.1908/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720754651 CMS
Janssen Biotech, Inc. $36.8208/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370797 CMS
Horizon Therapeutics plc $20.9808/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426643 CMS
Amgen Inc. $21.4008/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274891 CMS
Amgen Inc. $28.2108/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274901 CMS
Amgen Inc. $12.5608/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274917 CMS
Novartis Pharmaceuticals Corporation $17.6508/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042025 CMS
Novartis Pharmaceuticals Corporation $10.9708/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042029 CMS
Lilly USA, LLC $20.3208/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728621105 CMS
PFIZER INC. $31.1308/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743304081 CMS
RedHill Biopharma Inc. $35.3808/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730053393 CMS
Horizon Therapeutics plc $28.2907/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426641 CMS
Janssen Biotech, Inc. $32.8107/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370795 CMS
Janssen Biotech, Inc. $0.9007/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370803 CMS
Janssen Biotech, Inc. $5.5507/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370805 CMS
Amgen Inc. $27.8107/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274915 CMS
GlaxoSmithKline, LLC. $23.6807/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738514623 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.4907/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720754657 CMS
AbbVie Inc. $23.9307/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722050609 CMS
Amgen Inc. $31.4307/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741432747 CMS
Lilly USA, LLC $24.6607/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728624347 CMS
RedHill Biopharma Inc. $24.0007/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730053391 CMS
Amgen Inc. $14.9907/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274889 CMS
Amgen Inc. $9.5007/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274911 CMS
SANOFI-AVENTIS U.S. LLC $23.7506/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744261573 CMS
Horizon Therapeutics plc $16.7106/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426639 CMS
Novartis Pharmaceuticals Corporation $19.3806/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042022 CMS
Horizon Therapeutics plc $26.2106/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426637 CMS
Novartis Pharmaceuticals Corporation $4.3706/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042019 CMS
PFIZER INC. $37.2806/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743227437 CMS
Amgen Inc. $5.2006/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274909 CMS
Horizon Therapeutics plc $11.7005/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426635 CMS
Amgen Inc. $19.6405/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274887 CMS
Novartis Pharmaceuticals Corporation $22.5205/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042015 CMS
Janssen Biotech, Inc. $35.5805/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719370811 CMS
GlaxoSmithKline, LLC. $25.7105/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738514257 CMS
Horizon Therapeutics plc $26.5305/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426633 CMS
Amgen Inc. $33.0805/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741432745 CMS
GENZYME CORPORATION $24.8504/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744261533 CMS
GlaxoSmithKline, LLC. $23.6804/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738514209 CMS
PFIZER INC. $22.1604/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743173911 CMS
Horizon Therapeutics plc $15.4904/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426631 CMS
Amgen Inc. $20.4704/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741274885 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32.2203/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720754235 CMS
Horizon Therapeutics plc $15.7403/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721426629 CMS
Novartis Pharmaceuticals Corporation $4.5003/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726042013 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,825.26 217
PY2020 $7,630.79 142
PY2021 $4,918.11 179
PY2022 $5,992.51 233
PY2023 $4,652.52 212
PY2024 $4,379.08 185
PY2025 $3,317.04 142

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $70,977.56 13
PY2024 Principal investigator $5,120.58 5
PY2023 Principal investigator $16,358.02 10
PY2022 Principal investigator $12,116.09 5
PY2021 Principal investigator $41,325.22 13
PY2020 Principal investigator $55,266.95 15
PY2019 Principal investigator $13,369.20 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $176.66 12/31/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH CENTER
A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and who had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH) No dispute reported 06/30/2026 1202534879
Principal investigator 1 UCB SA $7,500.00 11/27/2025 Non-covered Recipient Entity
Valerius Medical Group And Research Center
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246659020
Principal investigator 1 ABBVIE INC. $1,657.80 10/09/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202513817
Principal investigator 1 UCB SA $37,980.85 09/05/2025 Non-covered Recipient Entity
Valerius Medical Group And Research Center
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246658232
Principal investigator 1 Aurinia Pharma U.S., Inc. $2,500.00 07/16/2025 Non-covered Recipient Entity
Valerius Medical Grp and Res Ctr of Greater Long B
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243931264
Principal investigator 1 ABBVIE INC. $1,799.55 07/02/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202493959
Principal investigator 1 Aurinia Pharma U.S., Inc. $450.00 05/07/2025 Non-covered Recipient Entity
Valerius Medical Grp and Res Ctr of Greater Long B
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243930757
Principal investigator 1 Aurinia Pharma U.S., Inc. $712.50 05/07/2025 Non-covered Recipient Entity
Valerius Medical Grp and Res Ctr of Greater Long B
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243930759
Principal investigator 1 ABBVIE INC. $1,799.55 05/06/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202481781
Principal investigator 1 ABBVIE INC. $1,120.00 03/13/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP
M16-011 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy No dispute reported 06/30/2026 1202463591
Principal investigator 1 Aurinia Pharma U.S., Inc. $7,020.00 03/12/2025 Non-covered Recipient Entity
Valerius Medical Grp and Res Ctr of Greater Long B
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243930984
Principal investigator 1 ABBVIE INC. $1,657.80 03/06/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH
M23-700 - Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202458333
Principal investigator 1 ABBVIE INC. $6,602.85 02/05/2025 Non-covered Recipient Entity
VALERIUS MEDICAL GROUP AND RESEARCH
M23-700 - Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202444544